Industry News
FDA Clears SB-007 Gene Therapy IND for Stargardt Disease

The FDA has cleared an Investigational New Drug (IND) application for SB-007, an adeno-associated vi...

read more
FDA Clears SB-007 Gene Therapy IND for Stargardt Disease
December 13, 2024
Tenpoint Therapeutics and Visus Therapeutics Merge, Strengthening Ophthalmic Therapeutics Pipeline

Tenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respe...

read more
Tenpoint Therapeutics and Visus Therapeutics Merge, Strengthening Ophthalmic Therapeutics Pipeline
December 13, 2024
VSY Biotechnology GmbH Appoints Christian Bach as Managing Director

VSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, has announced the app...

read more
VSY Biotechnology GmbH Appoints Christian Bach as Managing Director
December 13, 2024
VisiRose Introduces Investigational Non-Invasive Therapy for Infectious Keratitis

VisiRose, a newly established company is advancing the development of Rose Bengal Photodynamic Antim...

read more
VisiRose Introduces Investigational Non-Invasive Therapy for Infectious Keratitis
December 12, 2024
Nona Biosciences and Kodiak Sciences Collaborate to Develop Novel Antibodies for Ophthalmic Diseases

Nona Biosciences has announced a strategic partnership with Kodiak Sciences Inc. to advance the deve...

read more
Nona Biosciences and Kodiak Sciences Collaborate to Develop Novel Antibodies for Ophthalmic Diseases
December 11, 2024
ViaLase and Moran Eye Center Partner to Advance Glaucoma Research and Innovation

ViaLase has announced a groundbreaking research partnership with the John A. Moran Eye Center at the...

read more
ViaLase and Moran Eye Center Partner to Advance Glaucoma Research and Innovation
December 11, 2024
Nonsteroidal Immunomodulator VVN461 Meets Endpoints in Post-Cataract Surgery Inflammation Trial

VivaVision Biotech has announced promising phase 2 clinical trial results for VVN461, a nonsteroidal...

read more
Nonsteroidal Immunomodulator VVN461 Meets Endpoints in Post-Cataract Surgery Inflammation Trial
December 10, 2024
OneSight EssilorLuxottica Foundation Partners with WHO on SPECS 2030 Initiative

The OneSight EssilorLuxottica Foundation has entered a strategic partnership with the World Health O...

read more
OneSight EssilorLuxottica Foundation Partners with WHO on SPECS 2030 Initiative
December 09, 2024
Cambium Bio Secures Funding to Advance Dry Eye Disease Treatment

Cambium Bio Limited, a clinical-stage regenerative medicine company, announced that it has successfu...

read more
Cambium Bio Secures Funding to Advance Dry Eye Disease Treatment
December 06, 2024
Galimedix Therapeutics Begins Phase 1 Clinical Trial for Oral GAL-101

Galimedix Therapeutics Inc. has announced the initiation of dosing in a Phase 1 clinical trial for o...

read more
Galimedix Therapeutics Begins Phase 1 Clinical Trial for Oral GAL-101
December 06, 2024
More